Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cells

Apoptosis

Volumn 16, Issue 3, 2011, Pages 301-310

  Wang, Fei ^a,b   Liu, Jianfeng ^a   Robbins, Delira ^a   Morris, Kerri ^c   Sit, Amos ^a   Liu, Yong Yu ^c   Zhao, Yunfeng ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Apoptosis; Lymphoma; Mitochondria; p53

Indexed keywords

DOXORUBICIN; ELLIPTICINE; MUTANT PROTEIN; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE);

ARTICLE; CANCER RESISTANCE; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; GENE TRANSLOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOMA; LYMPHOMA CELL; MITOCHONDRION; MUTATION; PRIORITY JOURNAL;

BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX II; ELLIPTICINES; HUMANS; LYMPHOMA; MITOCHONDRIA; MUTANT PROTEINS; MUTATION; PROTEIN TRANSPORT; SMALL MOLECULE LIBRARIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952190281     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0559-8     Document Type: Article

References (39)

1. JJ Levine 1997 p53, the cellular gatekeeper for growth and division Cell 88 323 331 9039259 10. (Pubitemid 27131374)
2. M Hollstein K Rice MS Greenblatt T Soussi R Fuchs, et al. 1994 Datebase of p53 gene somatic mutations in human tumors and cell lines Nucleic Acids Res 22 3551 3555 7937055 1:CAS:528:DyaK2cXmslers7k%3D (Pubitemid 24299821)
3. I Garcia-Cao M Garcia-Cao J Martin-Caballero LM Criado P Klatt, et al. 2002 "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally EMBO J 21 6225 6235 12426394 10.1093/emboj/cdf595 1:CAS:528:DC%2BD38XptFOrsbs%3D (Pubitemid 35415339)
4. SD Tyner S Venkatachalam J Choi S Jones N Ghebranious, et al. 2002 p53 mutant mice that display early ageing-associated phenotypes Nature 415 45 53 11780111 10.1038/415045a 1:CAS:528:DC%2BD38Xkt1Kgsg%3D%3D (Pubitemid 34062443)
5. HP Jia 2006 Controversial Chinese gene-therapy drug entering unfamiliar territory Nat Rev Drug Discov 4 269 270 10.1038/nrd2017
6. T Tokino Y Nakamura 2000 The role of p53-target genes in human cancer Crit Rev Oncol Hematol 33 1 6 10714958 10.1016/S1040-8428(99)00051-7 1:STN:280:DC%2BD3c7nslCnsg%3D%3D (Pubitemid 30064481)
7. UM Moll A Zaika 2001 Nuclear and mitochondrial apoptotic pathways of p53 FEBS Lett 493 65 69 11286997 10.1016/S0014-5793(01)02284-0 1:CAS:528: DC%2BD3MXitl2it7g%3D (Pubitemid 32245778)
8. PF Li R Dietz R von Harsdorf 1999 p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2 EMBO J 18 6027 6036 10545114 10.1093/emboj/18.21.6027 1:CAS:528:DyaK1MXns1entro%3D (Pubitemid 29515679)
9. ND Marchenko AI Zaika UM Moll 2000 Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling J Biol Chem 275 16202 16212 10821866 10.1074/jbc.275.21.16202 1:CAS:528: DC%2BD3cXjvFaitL0%3D (Pubitemid 30366932)
10. S Erster M Mihara RH Kim O Petrenko UM Moll 2004 In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation Mol Cell Biol 24 6728 6741 15254240 10.1128/MCB.24.15.6728-6741.2004 1:CAS:528:DC%2BD2cXmtlKlur4%3D (Pubitemid 38944352)
11. Y Zhao L Chaiswing JM Velez I Batinic-Haberle NH Colburn, et al. 2005 p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase Cancer Res 65 3745 3750 15867370 10.1158/0008-5472.CAN-04-3835 1:CAS:528: DC%2BD2MXjslGksrw%3D (Pubitemid 40616352)
12. M Mihara S Erster A Zaika O Petrenko T Chittenden, et al. 2003 p53 has a direct apoptogenic role at the mitochondria Mol Cell 11 3 577 590 12667443 10.1016/S1097-2765(03)00050-9 1:CAS:528:DC%2BD3sXjtVWktrk%3D (Pubitemid 36385115)
13. K Heyne K Schmitt D Mueller V Armbruester P Mestres, et al. 2008 Resistance of mitochondrial p53 to dominant inhibition Mol Cancer 7 54 70 18547443 10.1186/1476-4598-7-54 (Pubitemid 351917272)
14. X Tang Y Zhu L Han AL Kim L Kopelovich, et al. 2007 CP-31398 reactivates mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice J Clin Invest 117 3753 3764 18060030 10.1172/JCI32481 1:CAS:528:DC%2BD2sXhsValsL7I (Pubitemid 350224086)
15. M Mahyar-Roemer C Fritzsche S Wagner M Laue K Roemer 2004 Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells Oncogene 23 6226 6236 15247902 10.1038/sj.onc.1207637 1:CAS:528:DC%2BD2cXmslCmtrY%3D (Pubitemid 39215293)
16. R Allman RJ Errington PJ Smith 2003 Delayed expression of apoptosis in human lymphoma cells undergoing low-dose taxol-induced mitotic stress Br J Cancer 88 1649 1658 12771935 10.1038/sj.bjc.6600905 1:CAS:528: DC%2BD3sXktVentr8%3D (Pubitemid 36713795)
17. C Gao T Nakajima Y Taya N Tsuchida 1999 Activation of p53 in MDM2-overexpressing cells through phosphorylation Biochem Biophys Res Commun 264 860 864 10544021 10.1006/bbrc.1999.1611 1:CAS:528:DyaK1MXmvFOms74%3D
18. G Gaidano P Ballerini JZ Gong G Inghirami A Neri, et al. 1991 p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia Proc Natl Acad Sci USA 88 5413 5417 2052620 10.1073/pnas.88.12.5413 1:CAS:528:DyaK3MXlslKgt7k%3D (Pubitemid 21914755)
19. KG Wiman KP Magnusson T Ramqvist G Klein 1991 Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240 Oncogene 6 1633 1639 1923530 1:CAS:528:DyaK3MXmsFejt7c%3D (Pubitemid 21924267)
20. MB Karpova D Sanmun JI Henter AF Smirnov B Fadeel 2006 Betulinic acid, a natural cytotoxic agent, fails to trigger apoptosis in human Burkitt's lymphoma-derived B-cell lines Int J Cancer 118 246 252 16003746 10.1002/ijc.21311 1:CAS:528:DC%2BD2MXht1KgsrvE (Pubitemid 41681606)
21. HC Yen TD Oberley S Vichitbandha YS Ho DK St Clair 1996 The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice J Clin Invest 98 1253 1260 8787689 10.1172/JCI118909 1:CAS:528:DyaK28XlsFakt7o%3D (Pubitemid 26299939)
22. Y Zhao LM Wang L Chaiswing HC Yen TD Oberley, et al. 2006 Tamoxifen protects against acute tumor necrosis factor alpha-induced cardiac injury via improving mitochondrial functions Free Radic Bio Med 40 1234 1241 10.1016/j.freeradbiomed.2005.11.009 1:CAS:528:DC%2BD28Xis1egurs%3D
23. VJ Bykov G Selivanova KG Wiman 2003 Small molecules that reactivate mutant p53 Eur J Cancer 39 1828 1834 12932659 10.1016/S0959-8049(03)00454-4 1:CAS:528:DC%2BD3sXmsVGlt7g%3D (Pubitemid 37311177)
24. A Duthu B Debuire J Romano JC Ehrhart M Fiscella, et al. 1992 p53 mutations in raji cells-characterization and localization relative to other burkitt's lymphomas Oncogene 7 2161 2167 1437144 1:CAS:528:DyaK3sXmsVKqsbk%3D
25. RJ Donahue M Razmara JB Hoek TB Knudsen 2001 Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function FASEB J 15 635 644 11259382 10.1096/fj.00-0262com 1:CAS:528:DC%2BD3MXitFWms7c%3D (Pubitemid 32245982)
26. S Matoba JG Kang WD Patino A Wragg M Boehm, et al. 2006 p53 regulates mitochondrial respiration Science 312 1650 1653 16728594 10.1126/science.1126863 1:CAS:528:DC%2BD28XlsFeqtLo%3D (Pubitemid 43902663)
27. T Soussi 2007 p53 alterations in human cancer: more questions than answers Oncogene 26 2145 2156 17401423 10.1038/sj.onc.1210280 1:CAS:528:DC%2BD2sXjs1yqt7s%3D (Pubitemid 46536642)
28. G Achanta R Sasaki L Feng JS Carew W Lu, et al. 2005 Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma EMBO J 24 3482 3492 16163384 10.1038/sj.emboj.7600819 1:CAS:528: DC%2BD2MXhtVKns7zF (Pubitemid 41486785)
29. Y Yoshida H Izumi T Torigoe H Ishiguchi H Itoh, et al. 2003 p53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA Cancer Res 63 3729 3734 12839966 1:CAS:528:DC%2BD3sXltVGqsrw%3D (Pubitemid 36793059)
30. CR Brown LQ Hong-Brown WJ Welch 1997 Correcting temperature-sensitive protein folding defects J Clin Invest 99 1432 1444 9077553 10.1172/JCI119302 1:CAS:528:DyaK2sXitVWrtbY%3D (Pubitemid 27142781)
31. G Selivanova T Kawasaki L Ryabchenko KG Wiman 1998 Reactivation of mutant p53: a new strategy for cancer therapy Semin Cancer Biol 8 369 378 10101802 10.1006/scbi.1998.0099 1:CAS:528:DyaK1MXitlSksL8%3D (Pubitemid 29131358)
32. E Sugikawa T Hosoi 1999 Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine Anticancer Res 19 3099 3108 10652599 1:CAS:528:DC%2BD3cXmvF2muw%3D%3D (Pubitemid 30042597)
33. AC Huff KN Kreuzer 1990 Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases J Biol Chem 265 20496 20505 2173709 1:CAS:528:DyaK3cXlvVClur8%3D (Pubitemid 120014036)
34. Y Peng C Li L Chen S Sebti J Chen 2003 Rescue of mutant p53 transcription function by ellipticine Oncogene 22 4478 4487 12881704 10.1038/sj.onc.1206777 1:CAS:528:DC%2BD3sXls1yntb4%3D (Pubitemid 36920691)
35. M Stiborová J Sejbal L Borek-Dohalská D Aimová J Poljaková, et al. 2004 The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide Cancer Res 64 8374 8380 15548707 10.1158/0008-5472.CAN-04-2202 (Pubitemid 39496831)
36. FA Fornari JK Randolph JC Yalowich MK Ritke DA Gewirtz 1994 Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells Mol Pharmacol 45 649 656 8183243 1:CAS:528:DyaK2cXivV2lsL8%3D (Pubitemid 24139191)
37. WJ Pigram W Fuller LD Hamilton 1972 Stereochemistry of intercalation: interaction of daunomycin with DNA Nature New Biol 235 17 19 4502404 10.1038/235017a0 1:CAS:528:DyaE38XhtVymtLw%3D
38. M Ohashi E Sugikawa N Nakanishi 1995 Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism Jpn J Cancer Res 86 819 827 7591958 1:CAS:528:DyaK28XlsVGqtQ%3D%3D
39. A Hubert S Paris JP Piret N Ninane M Raes, et al. 2006 Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level J Cell Sci 119 3351 3362 16882692 10.1242/jcs.03069 1:CAS:528:DC%2BD28XhtVart73L (Pubitemid 44405220)